Related Experiment Video
Updated: Jun 22, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
Obesity and paediatric migraine
1Department of Paediatric Endocrinology, Baskent University, Ankara, Turkey. stkinik@hotmail.com
Cephalalgia : an International Journal of Headache
|June 4, 2009
Summary
Obesity in children is linked to more frequent migraine attacks, although it doesn't worsen pain severity or duration. This finding highlights the importance of weight management in pediatric migraine care.
Area of Science:
- Pediatric Neurology
- Obesity Research
- Headache Medicine
Background:
- Migraine is a common neurological disorder in children.
- The role of obesity in pediatric migraine severity is not fully understood.
Purpose of the Study:
- To investigate the association between obesity and migraine characteristics in children.
- To compare headache features in obese, overweight, and normal-weight pediatric migraine patients.
Main Methods:
- A cohort of 124 children (mean age 12.9 years) with migraine was analyzed.
- Patients were categorized by weight status: obese, overweight, and normal weight.
- Headache frequency, duration, pain severity, and associated symptoms were compared across groups.
Main Results:
- Obese children experienced significantly more frequent monthly migraine attacks (5.3) compared to overweight (4.4) and normal-weight (3.8) children.
- A positive correlation was found between relative body mass index and headache attack frequency.
- Obesity did not significantly influence migraine pain severity, duration, or associated symptoms like aura, nausea, or photophobia.
Conclusions:
- Obesity is associated with an increased frequency of migraine attacks in children and adolescents.
- Weight management may be a relevant strategy for reducing headache burden in pediatric migraine patients.
- Further research is needed to elucidate the mechanisms linking obesity and migraine frequency in this population.
Related Concept Videos
01:24Obesity
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in adipocytes...
01:21Drug Dosing: Obese Patients
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
01:30Bulimia Nervosa
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...